MedTrace Logo

Increasing the Uptake of Advanced Directives in SingHealth Polyclinics

NCT03499847 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 189

Last updated 2019-09-24

No results posted yet for this study

Summary

An Advanced Medical Directive (AMD) is a legal document in Singapore that allows one to inform their medical practitioner that they do not want any life-sustaining treatment should they become unconscious and terminally ill where death is imminent. Despite the AMD act being passed in Singapore Parliament in 1996, uptake remains low among the population. Several intervention studies have shown that education and communication can be effective in promoting end-of-life discussion and planning. In this study, we aim to compare the effectiveness of counselling sessions together with pamphlets, versus pamphlets alone, versus current care, in increasing the completion rates of the AMD in the Singapore Polyclinic setting.

Conditions

  • Advanced Medical Directive, a Legal Document Signed in Advance to State Healthcare Preferences

Interventions

BEHAVIORAL

standardised face-to-face counselling session

the healthcare provider will conduct a standardised face-to-face counselling session guided with subjects guided by a check-list of topics to cover regarding the Advanced Medical Directive.

BEHAVIORAL

advanced medical directive pamphlet

A standardised pamphlet containing information about the Advanced Medical Directive produced by the Ministry of Health, Singapore.

Sponsors & Collaborators

  • SingHealth Polyclinics

    lead OTHER

Principal Investigators

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
41 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-29
Primary Completion
2018-12-19
Completion
2018-12-19

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03499847 on ClinicalTrials.gov